Dixon
JM
Select, Recent Publications
Estrone
and estradiol metabolism in vivo in human breast cysts.
Levitz
M. Raju U, Sepkovic DW, Miller WR, Dixon JM, Bradlow HL, Steroids.
2000;65:883-8.
ABC
of breast diseases. Breast cancer-epidemiology, risk factors,
and genetics. [Review].
McPherson
K, Steel CM, Dixon JM. BMJ. 2000;321:624-8.
Concentrations
of tamoxifen and its major metabolites in hormone responsive
and resistant breast tumours.
MacCallum
J, Cummings J, Dixon JM, Miller WR. British Journal of Cancer.
2000;82:1629-35.
Antiproliferative
effects of idoxifene in a placebo-controlled trial in primary
human breast cancer.
Dowsett
M, Dixon JM, Horgan K, Salter J, Hills M, Harvey E. Clinical
Cancer Research. 2000;6:2260-7.
The
effects of neoadjuvant anastrozole (Arimidex) on tumor volume
in postmenopausal women with breast cancer: a randomized,
double-blind, single-center study.
Dixon
JM, Renshaw L, Bellamy C, Stuart M, Hoctin-Boes G, Miller
WR. Clinical Cancer Research. 2000;6:2229-35.
Effective
tamoxifen therapy of breast cancer involves both antiproliferative
and pro-apoptotic changes.
Cameron
DA, Keen JC, Dixon JM, et al. European Journal of Cancer.
2000;36:845-51.
Magnetic
resonance imaging screening in women at genetic risk of breast
cancer: imaging and analysis protocol for the UK multicentre
study.
Brown
J, Buckley D, Coulthard A, et al. UK MRI Breast Screening
Study Advisory Group. Magnetic Resonance Imaging. 2000;18:765-76.
Reproducibility
of microvessel counts in breast cancer specimens.
Marson
LP, Kurian KM, Miller WR, Dixon JM. British Journal of Cancer.
1999;81:1088-93.
Investigation
of endometrial abnormalities in asymptomatic women treated
with tamoxifen and an evaluation of the role of endometrial
screening [see comments].
Love
CD, Muir BB, Scrimgeour JB, Leonard RC, Dillon P, Dixon JM.
Journal of Clinical Oncology. 1999;17:2050-4.
Risk
of breast cancer in women with palpable breast cysts: a prospective
study.
Dixon
JM, McDonald C, Elton RA, Miller WR. Edinburgh Breast Group.
Lancet. 1999;353:1742-5.
Accuracy
of intraoperative frozen-section analysis of axillary nodes.
Edinburgh Breast Unit team [see comments].
Dixon
JM, Mamman U, Thomas J. British Journal of Surgery. 1999;86:392-5.
Lessons
from the use of aromatase inhibitors in the neoadjuvant setting.
[Review].
Dixon
JM, Love CD, Renshaw L, et al. Endocrine-Related Cancer. 1999;6:227-30.
Breast
lumps in young women. New technique has excellent cosmetic
results [letter].
Dixon
JM, Venizelos B, Matheson L. BMJ. 1998;317:209-10.
Clinical
importance of intratumoral aromatase. [Review].
Miller
WR, Mullen P, Telford J, Dixon JM. Breast Cancer Research
& Treatment. 49 Suppl 1:S27-32; Discussion S33-7, 1998.
The
primary use of endocrine therapies. [Review].
Howell
A, Anderson E, Blamey R, et al. Recent Results in Cancer Research.
152:227-44, 1998.
Letrozole
as primary medical therapy for locally advanced and large
operable breast cancer (Meeting abstract).
Dixon
JM, Love CD, Tucker S, Bellamy C, Leonard RC, Miller WR. Proc
Annu Meet Am Soc Clin Oncol. 17:A400, 1998.
|
